Amitiza (lubiprostone) will come in a new lower strength for treating irritable bowel syndrome with constipation (IBS-C)

Amitiza (lubiprostone) will come in a new lower strength for treating irritable bowel syndrome with constipation (IBS-C).

It's the only drug approved for this condition now that Zelnorm (tegaserod) is restricted to emergency use only.

So far, this new indication is just for women...not men.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote